IP Verse

University Of Washington Through Its Center For Commercialization opposition analysis

COMPANY ANALYSIS

Patent:

Grant Date:

Jul 19, 2023

Title:

Hla Class Ii Deficient Cells, Hla Class I Deficient Cells Capable Of Expressing Hla Class Ii Proteins, And Uses Thereof

Oppositions:

Patent:

Grant Date:

Apr 7, 2021

Title:

Methods Of Lowering The Error Rate Of Massively Parallel Dna Sequencing Using Duplex Consensus Sequencing

Oppositions:

Patent:

Grant Date:

Nov 4, 2020

Title:

Beta-2 Microglobulin-Deficient Cells

Oppositions:

Patent Number	Grant Date	Title	Total Oppositions
EP2838548	Jul 19, 2023	Hla Class Ii Deficient Cells, Hla Class I Deficient Cells Capable Of Expressing Hla Class Ii Proteins, And Uses Thereof	2
EP2828218	Apr 7, 2021	Methods Of Lowering The Error Rate Of Massively Parallel Dna Sequencing Using Duplex Consensus Sequencing	3
EP2699593	Nov 4, 2020	Beta-2 Microglobulin-Deficient Cells	1

JAMES POOLE LIMITED

LEWIS SILKIN LLP

MARGARET DIXON LIMITED

Feel free to send us a message here and we will get back to you